Induction of cytoplasmic dsDNA and cGAS-STING immune signaling after exposure of breast cancer cells to X-rays or high energetic carbon ions

Cristina Totis,Nicole B. Averbeck,Burkhard Jakob,Maik Schork,Gaia Volpi,Dennis F. Hintze,Marco Durante,Claudia Fournier,Alexander Helm
DOI: https://doi.org/10.1101/2024.07.23.604756
2024-07-23
Abstract:Radiotherapy can trigger activation of the cGAS-STING axis via cytoplasmic dsDNA fragment induction. The activation of cGAS-STING initiates innate immune signaling mediated by interferon type-I that can contribute to eradicate the malignancy. The effect was shown to depend on the fractionation scheme employed. We hypothesized that the innate immune response can also depend on radiation quality because densely ionizing radiation, such as carbon ions, have different effects on DNA lesion quality. We show here that carbon ions induced a significantly higher yield of cytosolic dsDNA fragments per unit dose as compared to photons in an in vitro 4T1 breast cancer model. The higher efficiency also translated in expression and release of interferon-beta by the tumor cells. Cytoplasmic dsDNA fragments as well as interferon-beta release increased with doses up to 24 Gy and no differences for a fractionation scheme (3x8 Gy) were found as compared to the single high doses of photons. In conclusion, we found that the release of interferon-beta after radiation is increasing with the radiation dose up to 20 Gy and that carbon ions have the potential to elicit a strong innate immune signaling.
Biophysics
What problem does this paper attempt to address?
The paper primarily explores the effects of Carbon Ion RadioTherapy (CIRT) in inducing cytoplasmic double-stranded DNA (dsDNA) fragments and activating the cGAS-STING immune signaling pathway in breast cancer cells, comparing it with X-ray radiation. Specifically, the research team focused on: 1. **The impact of carbon ion radiation on breast cancer cells**: The study found that carbon ion radiation is more effective than X-rays in killing triple-negative breast cancer cells (4T1 cell line) and can induce more cytoplasmic dsDNA fragments. 2. **Enhancement of immune response**: Carbon ion radiation can also significantly increase the expression and release of interferon-β (IFN-β) in tumor cells, indicating that CIRT has a stronger ability to trigger innate immune signals, which may help enhance immunogenicity. 3. **Dose response**: The study also explored the effects of different doses and fractionated dosing schemes (e.g., 3 times 8Gy) on the above effects. The results showed that in some cases, a single high dose (e.g., 24Gy) did not differ significantly from fractionated dosing schemes. 4. **Comparison with previous studies**: Unlike previous studies, this paper did not observe a nonlinear dose-response pattern, meaning that a specific dose range (8-12Gy) did not show particular advantages. Additionally, the study found lower CXCR3 gene expression after carbon ion radiation, which may be related to reduced metastatic potential. In summary, this paper aims to support the potential application of carbon ion radiation in breast cancer treatment through experimental data, especially when combined with immunotherapy, although further research is needed to confirm its advantages.